clinical trial · NCT06337604
The Safety and Tolerability, Pharmacokinetics of TNP-2092 Capsules in Combination With Rabeprazole Sodium Enteric-coated Tablets
Helicobacter Pylori InfectionTNP-2092 capsulesTNP-2092 capsules placeboRabeprazole sodium enteric-coated tablets
brief summary
A phase 1, single-center, double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and tolerability, pharmacokinetics, and preliminary efficacy of multiple administrations of TNP-2092 Capsules in combination with Rabeprazole Sodium Enteric-coated Tablets in asymptomatic healthy subjects with Helicobacter pylori infection
started
Oct 10, 2017
primary completion
Nov 23, 2017
completion
Nov 23, 2017
last updated
Apr 1, 2024
official title
A Phase 1, Single-center, Double-blind, Randomized, Placebo-controlled Clinical Trial to Evaluate the Safety and Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Administrations of TNP-2092 Capsules in Combination With Rabeprazole Sodium Enteric-coated Tablets in Asymptomatic Healthy Subjects With Helicobacter Pylori Infection
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol